PROCEPT BioRobotics
PROCEPT BioRobotics offers Aquablation therapy, a minimally invasive, heat-free robotic treatment for benign prostatic hyperplasia (BPH), utilizing the AquaBeam Robotic System for precise prostate tissue removal.
Aquablation Therapy for Benign Prostatic Hyperplasia (BPH)
Aquablation therapy is a minimally invasive, heat-free robotic therapy designed to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). This innovative procedure combines cystoscopic visualization with ultrasound imaging, providing a multidimensional view of the prostate. This allows for a precise and consistent removal of prostate tissue, regardless of the prostate's size or shape.
AquaBeam Robotic System
The AquaBeam Robotic System is the technology behind Aquablation therapy. This system utilizes a robotically controlled, heat-free waterjet to achieve precise tissue resection. It is the first FDA-cleared surgical robot that uses automated tissue resection for treating LUTS due to BPH. The system incorporates real-time, multidimensional imaging, personalized treatment planning, and automated robotics to deliver consistent outcomes.
Effectiveness and Safety of Aquablation Therapy
Aquablation therapy's efficacy and safety are well-documented, with backing from nine different clinical trials. These trials have demonstrated the therapy's effectiveness, safety, and durability. The therapy has low rates of irreversible complications such as erectile dysfunction, ejaculatory dysfunction, and incontinence. Aquablation therapy is proven to be effective in treating both large prostates (80-150 cc) as well as smaller prostates.
Insurance Coverage for Aquablation Therapy
Aquablation therapy is covered by Medicare, Medicare Advantage, Tricare, and many commercial insurance plans, provided medical criteria are met. This broad insurance coverage facilitates access to the therapy for many patients suffering from BPH.
Clinical Procedure and Outcomes
Aquablation therapy is performed in an operating room setting, usually under spinal or general anesthesia, and typically involves an overnight hospital stay. The AquaBeam Robotic System enables rapid and highly consistent resection times across all prostate sizes and shapes. The procedure's design aims to deliver predictable, reproducible outcomes, enhancing the treatment's reliability.